The neurohaemal part of the median eminence of the rat hypothalamus is characterized by numerous nerve terminals which end near a rich network of fenestrated capillaries. An attempt was made to isolate different types of nerve terminals by means of sucrose density-gradient centrifugation. The subcellular fractions obtained were assayed for dopamine, noradrenaline and 5-hydroxytryptamine. In addition FSH-and GH-releasing activities were determined. A sample of each fraction obtained was taken for electron microscopical observations. Dopamine, noradrenaline, 5-hydroxytryptamine, GH-and FSH-releasing factors were present in higher concentration in the nerve endings. A further fractionation showed that noradrenaline was present in the lightest synaptosomal band, dopamine in the middle one, and 5-hydroxytryptamine in the heaviest. GH-RF and FSH-RF were recovered mainly from the band containing dopamine. The relevance of this localization to the physiological role of the median eminence is discussed.
INTRODUCTION
It has been established that neurotransmitters (such as noradrenaline, dopamine and 5-hydroxytryptamine) and hypothalamic releasing factors are present in the median eminence of the rat. Noradrenaline and dopamine were detected in this tissue by means of histochemical fluorescence techniques and, by the same method, the distribution of these substances was carefully investigated (Akmayev, 1969; Fuxe & Hökfelt, 1969; Björklund, Falk, Hromek, Owman & West, 1970 Szentágothai, Flerkó, Méss & Halász, 1968) . It is now believed that the hypothalamo-hypophysiotrophic principles are released in the neurohaemal zone of the median eminence in the vicinity of the pituitary portal vessels and thence transported to the pituitary. This zone is richer in monoamines and contains numerous nerve endings terminating very closely to the fenestrated capillaries of the pituitary portal vessels (Röhlich, Vigh, Teichman & Aros, 1965; Rinne, 1966; Monroe, 1967; . In spite of several investigations carried out with the aim of clarifying the precise subcellular distribution of amines in the median eminence, this is still a matter of debate (Hökfelt, 1967 (Hökfelt, , 1968 Pellegrino De Iraldi & Etcheverry, 1967;  Rinne, Sonninen & Helminen, 1967 
Fractionation procedures
The median eminences were homogenized in 0-32 M-sucrose (10%, w/v) in a modified Perspex Aldridge homogenizer (Whittaker & Dowe, 1965) . From the homogenate primary fractions (P1; crude nuclear fractions; P2, crude synaptosomal fractions, and S, supernatant) were obtained by the procedure of Gray & Whittaker (1962) . Further fractionation of P2, resuspended in 0-32 M-sucrose in a discontinuous gradient consisting of 4 ml layers of 1·2, 1-0, 0-8 and 0-6 M-sucrose, prepared 2 h earlier in a cold-room and centrifuged for 2 h at 63000g (average) in a Beckman L-2 centrifuge with a type SW25-1 rotor (modified from Hebb & Whittaker, 1958 (Karnovsky, 1965) Shore & Olin (1958) . 5-Hydroxytryptamine (5-HT) was determined using the extraction method of Bogdanski, Pletscher, Brodie & Udenfriend (1956) and the ninhydrin fluorescence activation procedure of Snyder, Axelrod & Zweig (1965) . The recovery with these methods was within 70 and 85%. GH-RF and FSH-RF activity
The GH-RF and FSH-RF activities of the hypothalamic homogenate and of the fractions were determined by the 'pituitary depletion' methods of Pecile, Müller, Falconi & Martini (1965) and David, Fraschini & Martini (1965) , respectively (see also Motta, Piva, Fraschini & Martini, 1970) . The acidic homogenate and the acidic fractions were accurately neutralized with Na2C03 immediately before use. The neutralized solutions were then injected in amounts of 0-2 ml (corresponding to 1 crude median eminence) into the carotid artery of normal adult male rats anaes¬ thetized with pentobarbitone (3 mg/100 g) a few minutes before exposure of the artery. The animals were decapitated 30 min after injection for GH-RF assay and 20 min after injection for FSH-RF assay. The pituitaries of the recipient animals were quickly removed, cleaned, weighed to the nearest 0· 1 mg, homogenized in cold 0-9% NaCl solution and the GH content assayed by the 'tibia test' of Greenspan, Li, Simpson & Evans (1949) as modified by Reichlin (1961) , and the FSH content by the 'ovarian augmentation test' of Steelman & Pohley (1953) as modified by Parlow & Reichert (1963) . Samples of GH and FSH provided by NIH were used as reference standards (NIH-GH bovine 8 and NIH-FSH ovine S 4).
Vasopressin
Vasopressin was assayed in the homogenate and the fractions by the rat blood pressure method of Dekanski (1952) .
RESULTS

Morphology
The morphology of the primary fractions (Pl5 P2 and S) obtained by differential centrifugation of the homogenate was very similar to that described by many authors for primary fractions of the central nervous system (Gray & Whittaker, 1962) .
Sucrose density-gradient centrifugation of the P2 fraction produced four bands (A, Bv B2, B3) and a pellet (C) (Plate 2). Fraction A, on top of 0-6 M-sucrose, was a very thin band of membranes, myelin elements and few synaptosomes trapped in the latter. Bands B1; B2 and B3 were layered on 0-8, 1-0 and 1·2 M-sucrose, respectively, and showed almost exclusively synaptosome profiles (about 85% (Andreoli, Ceccarelli, Cerati, Demonte & Clementi, 1970) ) was low. The pellet (C) usually con¬ tained a large number of mitochondria, cell debris, granules, membranes and also nerve endings. 
Monoamines
Chemical analysis
The homogenates of rat median eminence contained NA, 420 + 38 (s.d.) ng/g; DA, 632 + 30 ng/g; 5-HT, 1410 ± 38 ng/g; and protein, 107 + 6 mg/g. The monoamines in the primary fractions were present in the highest concentration in the crude synaptosomal fraction P2 (Table 1) . Upon further fractionation of the pellet P2 noradrenaline was mainly localized in fractions Bx and B2 while dopamine was mainly recovered from fraction B2. The highest amount of 5-hydroxytryptamine was present in fraction B3 (Table 2) . When the values of NA, DA and 5-HT were expressed as relative specific activity (i.e. % amine recovered over % proteins recovered), the distribution of amines in the fractions was better defined and NA was present specific-ally in band B1, DA in band B2 and 5-HT in band B3 (Text-fig. 1 ). Proteins were present in all fractions with concentrations increasing in the bands with greatest density, reaching a maximum in the pellet (Table 1) . homogenate (5) Pi (l) P2 (3) S (3) Bu (8) , (3) , ( 
GH-RF activity
DISCUSSION
The monoamine content of the rat median eminence was similar to that reported by others and was lower than that in the whole hypo¬ thalamus (Andreoli et al. 1970) .
Histochemical fluorescence methods indicate that dopamine and noradrenaline are the main amines in the median eminence (Fuxe & Hokfelt, 1967 , 1969 Akmayev, 1969; Bjòrklund et al. 1970 ). However, it now seems that a considerable amount of 5-hydroxytryptamine is also present. Its occurrence may be of relevance in the control of the release of the hypothalamic factors or in the direct control of pituitary secretion. Noradrenaline also may have an important role in the control of release of GH-RF from the median eminence, as suggested by recent findings of Müller, Dal Pra & Pecile (1968) .
The significance of dopamine in the median eminence has been stressed recently. The dopamine content has been shown to change during the oestrous cycle (with higher levels at dioestrus) ; it is increased in pregnancy, lactation and after treatment with sex hormones, and decreased after hypophysectomy (Fuxe, Hökfelt & Nilsson, 1967; Fuxe & Hökfelt, 1969 Kamberi, Mical & Porter (1969) . On the other hand, the pre¬ sence in the median eminence of noradrenaline and 5-hydroxytryptamine suggests that dopamine may not be the only mediator controlling the release of hypothalamic principles.
The subcellular distribution of monoamines and of the releasing factors showed that these substances are present in the nerve endings. The fact that dopamine, nor¬ adrenaline and 5-hydroxytryptamine were localized in different bands after densitygradient centrifugation strongly suggests that these neurotransmitters are stored in different populations of nerve endings. In spite of these clear biochemical differences the morphological examination of the bands did not reveal any significant differences among synaptosomes recovered from bands B1; B2 and B3. However, it is difficult to assess the size and shape of isolated synaptosomes after prolonged centrifugation in high sucrose concentration.
The results on the subcellular localization of GH-RF and FSH-RF indicate strongly that these releasing factors are stored neither in the nerve endings containing nor¬ adrenaline nor in those containing 5-hydroxytryptamine. In contrast, dopamine was found in the same band as GH-RF and FSH-RF. Dopamine and releasing factors may be stored in different types of nerve endings behaving similarly during the centri¬ fugation procedures or they may be stored in the same nerve endings, releasing factors being possibly stored in dense granules while dopamine could be stored in synaptic vesicles. The scant information available is consistent with this proposed localization of hypothalamic releasing factors inside nerve terminals (Kobayashi & Matsui, 1969; Ishii, 1970) . As far as the localization of monoamines is concerned, Hökfelt (1967 Hökfelt ( , 1968 found that monoamines are stored in small synaptic vesicles, that look like small dense-cored vesicles only after special incubation and fixation procedures (Hökfelt, 1967) . The close localization of dopamine and releasing factors is of special interest because of the possible role of dopamine in the control of median eminence functions. Dopamine could be released first and favour the release of the specific releasing factors by a modification of cell membrane permeability.
In conclusion, our experiments have shown that each neurotransmitter is stored in a different type of nerve ending and that at least two releasing factors (GH-RF and FSH-RF) are associated with the dopamine-containing nerve terminals. This distribution of releasing factors and dopamine may suggest that dopamine is in¬ volved in the control of the release of hypothalamic principles. 
